Aclaris Therapeutics Closes $21M Series A

Aclaris Therapeutics Inc., a specialty pharmaceutical company focused on dermatology, has raised $21 million. The Series A was led by Vivo Ventures and Fidelity Biosciences with participation from Sofinnova Ventures. The money will be used for product development.

North AmericaUSBriefs